Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program

René S. Kahn, Steven M. Silverstein, Daniel H. Wolf, Louise Birkedal Glenthøj, Swapna Verma, Carla Gerber, Sylvain Bouix, Leslie E. Horton, Jijun Wang, Ofer Pasternak, Melissa Kerr, Merete Nordentoft, Masoomeh Faghankhani, Barnaby Nelson, Jai Shah, Judy L. Thompson, Nicholas J. K. Breitborde, Rachel Upthegrove, Vijay A. Mittal, Andrew Thompson, Catalina Mourgues, Paolo Fusar‐Poli, Luis Alameda, Patricia Marcy, Martha E. Shenton, Dominic Oliver, Ángela Núñez, Stefan Smesny, Daniel H. Mathalon, Philippe Conus, Matthew R. Broome, Andrea M. Auther, Celso Arango, Gregory P. Strauss, William S. Stone, Nikolaos Koutsouleris, Kristin S. Cadenhead, Jean Addington, Barbara A. Cornblatt, Ricardo E. Carrión, Jun Soo Kwon, Amy Braun, Scott W Woods, Lu Liu, Dominic Dwyer, Lana Kambeitz‐Ilankovic, Michael Coleman, Cheryl M. Corcoran, Barbara C. Walsh, Alison R. Yung, Kathryn E. Lewandowski, Lauren M. Ellman, Sung‐Wan Kim, Matcheri S. Keshavan, John M. Kane, Covadonga M. Díaz‐Caneja, Joseph Kambeitz, Fred W. Sabb, Eric Chen, Diana O. Perkins, Monica E. Calkins, Godfrey D. Pearlson, Jason Schiffman, Kerstin Langbein, Jimmy Choi, Christy Lai Ming Hui, Albert R. Powers, Alana Wickham, Nora Penzel, Grace R. Jacobs, Jesús Pérez, Inge Winter-van Rossum, Jack D. Rogers, Carrie E. Bearden, Patrick D. McGorry, Heather M. Wastler, Kate Buccilli, Pablo A. Gaspar